Aidan Dewar, co-founder/CEO of Nourish, walks through how the dietitian-led metabolic care company has evolved from a pure lifestyle-change complement to GLP-1s into a full prescribing platform, and why timing that shift right took four years of deliberate positioning. The conversation covers Nourish&#x27;s differentiation thesis (scale, product, distribution, and above all execution), how the company built its AI stack from administrative automation to a full patient-facing AI health assistant and provider copilot, and Aidan&#x27;s view on where AI does and doesn&#x27;t replace clinicians. It closes with reflections on policy (incentive design, food-as-medicine momentum, MAHA), hiring in the AI era, and candid founder lessons. (0:00) Intro (0:42) Nourish Today Explained (2:12) Big Vision and Root Problems (3:31) GLP-1 Prescribing Strategy (5:47) How Nourish Wins (9:11) Reimagining Virtual Primary Care (10:56) Building In-House vs Partnering (12:18) AI for Providers and Patients (15:36) Meal Logging and Model Limits (16:30) Future of AI-Led Care (20:05) Food Partnerships and Coverage (22:44) Policy Momentum and MAHA (24:06) Dietitian Supply and Training (25:54) Running a Company with AI (28:07) Hiring for AI Proficiency (29:49) Quickfire Out-Of-Pocket: https://www.outofpocket.health/

Ep 70: Nourish CEO Aidan Dewar on Hiring in the AI Era, Future of GLP-1s and Scaling Metabolic Health

Vital Signs with Jacob Effron and Nikhil Krishnan

This is Vital Signs, a podcast on cutting-edge trends in health tech and the people shaping them. And today we have a very exciting guest, Aidan from Nourish. I'm sure our audience is quite familiar with Nourish, one of the more interesting health tech startups out there. Really focused on metabolic health, focused on building an incredible platform, dietician-focused. You've probably seen their very catchy branding and ads at some point. Thanks so much for coming on the pod, Aidan. Thanks for having me, Jacob. Yeah, it's a real pleasure. I feel like, I don't know if we timed it this way strategically, but you had some big fundraising news, recently.

We recently announced the 100 Million Series C, led by Menlo, and we're really excited about this next chapter. Well, I figured there were lots of things to dive into today that I'm sure our audience will want to know. But maybe at the start, would it be helpful to contextualize kind of both what Nourish does today, maybe how that's evolved over the course of the business, and then where you're hoping to take this thing over time? Yeah, happy to speak to it. So Nourish is a dietician-led metabolic clinic. What that means is a registered dietician is the first point of care for every patient,

and then we layer on additional types of care depending on patient acuity and need. This includes having physicians on staff that can deliver virtual medical care, but also order and interpret labs, prescribe and manage medications. GLP-1s, which I'm sure we'll talk about, are of course one of those medications, but we manage a number of different medications. And then every patient has an AI health agent as part of the care team.

Ep 70: Nourish CEO Aidan Dewar on Hiring in the AI Era, Future of GLP-1s and Scaling Metabolic Health

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Ep 70: Nourish CEO Aidan Dewar on Hiring in the AI Era, Future of GLP-1s and Scaling Metabolic Health

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.